Farther Finance Advisors’s Fennec Pharmaceuticals FENC Stock Holding History

Farther Finance Advisors’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03K	Sell	95 -185	-66%	-$1.51K	﹤0.01%	5370
2026 Q1	$1.79K	Buy	280 +6	+2%	+$46	﹤0.01%	4934
2025 Q4	$2.11K	Hold	274	–	–	﹤0.01%	4674
2025 Q3	$2.56K	Buy	+274	New	+$2.37K	﹤0.01%	4044

Other funds holding FENC

Eleva Capital Paris, France $343M AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's FENC Position: Q2 2026 in Review

Farther Finance Advisors reduced its Fennec Pharmaceuticals (FENC) stake by 66% in Q2 2026, selling an estimated $1.51K and leaving 95 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #5370.

Farther Finance Advisors first reported a position in FENC in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.56K in Q3 2025. 5 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

Farther Finance Advisors held 95 shares of Fennec Pharmaceuticals worth $1.03K as of Q2 2026.
Farther Finance Advisors sold 185 Fennec Pharmaceuticals shares in Q2 2026, an estimated $1.51K.
Fennec Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5370 holding.
Farther Finance Advisors first reported a position in Fennec Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
Farther Finance Advisors's Fennec Pharmaceuticals position peaked at $2.56K in Q3 2025.
5 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.